Australia · Delayed Price · Currency is AUD CONNEQT Health Company Description
CONNEQT Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific.
It offers SphygmoCor, a vascular biomarker platform that captures a peripheral arterial waveform from the upper-arm, wrist, or finger and convert it to a central pressure waveform to extract vascular biomarkers.
The company also provides medical and home health care devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders.
It sells its cardiovascular devices and services to individuals, hospitals, clinics, research institutions and pharmaceutical companies.
The company was formerly known as CardieX Limited and changed its name to CONNEQT Health Limited in September 2025.
CONNEQT Health Limited was founded in 1994 and is based in Sydney, Australia.
| Country | Australia |
| Founded | 1994 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Craig Cooper |
Contact Details
Address: 55 Lime Street Sydney, NSW 2000 Australia | |
| Phone | 61 2 9874 8761 |
| Website | conneqthealth.com |
Stock Details
| Ticker Symbol | CQT |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000420739 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Craig R. Cooper BEC, L.L.B. | Co-Founder, Group Chief Executive Officer, MD and Executive Director |
| Niall Charles Edgar Cairns ACA, B.Ec, FAICD | Co-Founder and Executive Chairman |
| Douglas T. Kurschinski | Executive Vice President and Head of Global Sales for AtCor Medical Division |
| Catherine Liao | Chief Strategy and Commercial Officer |
| Oliver Shay | Chief Digital Officer |
| Louisa Ho | Company Secretary |